Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

NOTARBARTOLO DI VILLAROSA, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.945
EU - Europa 4.408
AS - Asia 3.511
SA - Sud America 634
Continente sconosciuto - Info sul continente non disponibili 452
AF - Africa 119
OC - Oceania 5
Totale 17.074
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.737
SG - Singapore 1.226
IT - Italia 1.205
RU - Federazione Russa 1.004
CN - Cina 862
BR - Brasile 495
FI - Finlandia 470
HK - Hong Kong 365
UA - Ucraina 351
VN - Vietnam 336
DE - Germania 324
PL - Polonia 206
GB - Regno Unito 202
FR - Francia 172
IE - Irlanda 172
JP - Giappone 120
BD - Bangladesh 117
IN - India 105
CA - Canada 84
SE - Svezia 82
TR - Turchia 82
KR - Corea 51
MX - Messico 51
AR - Argentina 42
NL - Olanda 41
ES - Italia 32
IQ - Iraq 32
MY - Malesia 30
PK - Pakistan 26
BE - Belgio 25
EC - Ecuador 23
VE - Venezuela 23
ZA - Sudafrica 23
AT - Austria 22
BG - Bulgaria 22
MA - Marocco 22
RO - Romania 22
CO - Colombia 21
ID - Indonesia 20
CI - Costa d'Avorio 19
JM - Giamaica 16
PH - Filippine 16
EG - Egitto 15
SA - Arabia Saudita 14
CL - Cile 13
CR - Costa Rica 13
UZ - Uzbekistan 13
HN - Honduras 12
IR - Iran 12
LB - Libano 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 9
CZ - Repubblica Ceca 7
DZ - Algeria 7
LT - Lituania 7
SY - Repubblica araba siriana 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
TT - Trinidad e Tobago 6
AU - Australia 5
BO - Bolivia 5
EE - Estonia 5
JO - Giordania 5
NI - Nicaragua 5
NP - Nepal 5
PY - Paraguay 5
TH - Thailandia 5
UY - Uruguay 5
BH - Bahrain 4
ET - Etiopia 4
GR - Grecia 4
GT - Guatemala 4
KE - Kenya 4
MT - Malta 4
OM - Oman 4
PA - Panama 4
TW - Taiwan 4
AL - Albania 3
BB - Barbados 3
GE - Georgia 3
LY - Libia 3
PR - Porto Rico 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GH - Ghana 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
Totale 16.608
Salva come PNG Salva come JPEG
Città #
Ashburn 939
Singapore 814
Fairfield 634
San Jose 630
Houston 394
Chandler 381
Woodbridge 364
Palermo 360
Hong Kong 349
Wilmington 271
Ann Arbor 269
Seattle 237
Cambridge 199
Jacksonville 191
Council Bluffs 186
Zgierz 183
Moscow 181
Dublin 164
Beijing 147
Santa Clara 145
Des Moines 136
Los Angeles 128
Medford 128
Tokyo 113
Ho Chi Minh City 112
New York 109
Dallas 108
Frankfurt am Main 99
Lauterbourg 85
Boardman 84
Nanjing 84
Princeton 80
Hanoi 76
Helsinki 70
The Dalles 67
Altamura 62
Hefei 61
Tulsa 54
Buffalo 52
Lawrence 50
San Diego 50
São Paulo 47
Rome 45
Chicago 44
Dearborn 43
Milan 43
Atlanta 31
London 31
Shenyang 30
Izmir 29
Phoenix 29
Hebei 27
Venice 27
Brooklyn 25
Columbus 25
Nanchang 25
Toronto 25
Changsha 24
Nuremberg 23
Bremen 22
Brussels 22
Ludwigshafen am Rhein 22
Memphis 22
Shanghai 21
Abidjan 19
Denver 19
Sofia 19
Kuala Lumpur 18
Orem 18
Catania 17
Falls Church 16
Ningbo 16
San Paolo di Civitate 16
Messina 15
Verona 15
Warsaw 15
Zhengzhou 15
Brasília 14
Montreal 14
Rio de Janeiro 14
Seongnam 14
Tianjin 14
City of London 13
Jinan 13
Manchester 13
Salerno 13
San Francisco 13
Belo Horizonte 12
Hangzhou 12
Johannesburg 12
Munich 12
Naples 12
Stockholm 12
Amsterdam 11
Auburn Hills 11
Da Nang 11
Guangzhou 11
Haiphong 11
Jiaxing 11
New Delhi 11
Totale 10.030
Salva come PNG Salva come JPEG
Nome #
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION 335
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 316
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 297
Targeting Multiple Myeloma with natural polyphenols 293
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 285
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 277
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 263
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 263
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 261
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 258
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 254
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 253
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 245
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 243
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 241
USE OF HERBAL REMEDIES AMONG CANCER AND TRANSPLANT PATIENTS IN THE TOWN OF PALERMO, SICILY 241
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 238
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 235
Expression of the IAPs in multidrug resistant tumor cells 235
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 226
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 225
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 223
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 218
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 217
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 210
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 208
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 203
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 203
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 202
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 199
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 199
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 197
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 195
Unusual high dose of tacrolimus in liver transplant patient, a case report. 193
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 192
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 190
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 190
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis 187
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 187
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 184
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 178
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 176
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 176
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 176
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 175
Bioactive triterpenes of protium heptaphyllum gum resin extract display cholesterol-lowering potential 173
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 173
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 171
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 169
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 169
Use of herbal products among cancer and transplanted patients in the town of Palermo,Sicily. 168
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 167
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 164
null 164
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 164
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression. 158
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth 156
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 156
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 155
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 155
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 152
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 150
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 149
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 149
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines 149
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 148
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 147
Carrier capability of halloysite nanotubes for the intracellular delivery of antisense PNA targeting mRNA of neuroglobin gene 145
NF-κB is a potential pharmacological target in triple negative breast cancers. 144
Nanocarrier based on halloysite and fluorescent probe for intracellular delivery of peptide nucleic acids 140
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 137
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 137
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 136
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 133
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 133
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 128
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 128
Prostaglandin E2 receptors and COX enxymes in human hepatocellular carcinoma: role in the regulation of cell growth 128
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 128
Expression of HIP/PAP mRNA in Human Hepatoma Cell Lines 126
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 125
Cancer therapy and treatments during COVID-19 era 124
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 123
Ihnibitor of Apoptosis Proteins (IAPs) as a new possible therapeutic targets in hepatocellular cancer. 123
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 119
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities 118
Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance 116
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 115
Recovery of Bioactive Compounds from Marine Organisms: Focus on the Future Perspectives for Pharmacological, Biomedical and Regenerative Medicine Applications of Marine Collagen 113
Comparison of Synthetic Pathways for Obtaining Fluorescent Nanomaterials Based on Halloysite and Carbon Dots for Potential Biological Sensing 111
Supramolecular Association of Halochromic Switches and Halloysite Nanotubes in Fluorescent Nanoprobes for Tumor Detection 106
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 102
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 80
Design of innovative and low-cost dopamine-biotin conjugate sensor for the efficient detection of protein and cancer cells 74
null 67
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 47
Totale 17.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022799 0 0 30 21 44 28 74 40 98 166 90 208
2022/20231.271 134 214 26 145 158 203 101 80 125 10 60 15
2023/2024712 39 87 53 31 44 131 53 49 14 40 43 128
2024/20252.087 43 158 113 200 125 99 202 141 177 199 233 397
2025/20266.054 420 208 356 481 536 908 834 595 422 769 262 263
2026/20271.234 273 209 752 0 0 0 0 0 0 0 0 0
Totale 17.074